Politics, profit, and psychiatric diagnosis: A case study of tobacco use disorder

American Journal of Public Health

Volumn 104, Issue 11, 2014, Pages 2076-2084

  Hirshbein, Laura D ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; ECONOMICS; HISTORY; HUMAN; ORGANIZATION AND MANAGEMENT; POLITICS; TOBACCO INDUSTRY; TOBACCO USE DISORDER; UNITED STATES;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; HISTORY, 20TH CENTURY; HUMANS; POLITICS; TOBACCO INDUSTRY; TOBACCO USE DISORDER; UNITED STATES;

EID: 84907822143     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.302125     Document Type: Article

References (85)

1. Memo from Wakeham to Goldsmith, copy to Holtzman, Philip Morris, May 28, 1976, Legacy Tobacco Documents Library (LTDL), Bates no. 1005083104, http://legacy.library.ucsf.edu/tid/kgz18e00 (accessed August 1, 2014).
2. J. Kuzmarov, The Myth of the Addicted Army: Vietnam and the Modern War on Drugs (Amherst, MA: University of Massachusetts Press; 2009).
3. H. S. Decker, The Making of DSM-III: A Diagnostic Manual's Conquest of American Psychiatry (New York, NY: Oxford University Press, 2013);
4. S. A. Kirk and H. Kutchins, The Selling of DSM: The Rhetoric of Science in Psychiatry (New York, NY: Aldine de Gruyter, 1992).
5. R. Bayer, Homosexuality and American Psychiatry: The Politics of Diagnosis, revised ed. (Princeton, NJ: Princeton University Press; 1987).
6. A. M. Brandt, The Cigarette Century: The Rise, Fall, and Deadly Persistence of the Product That Defined America (New York, NY: Basic Books, 2007);
7. M. D. Neuman, A. Bitton, and S. A. Glantz, "Tobacco Industry Influence on the Definition of Tobacco Related Disorders by the American Psychiatric Association," Tobacco Control 14 (2005): 328-337.
8. R. Mayes and A. V. Horwitz, "DSM-III and the Revolution in the Classification of Mental Illness," Journal of the History of the Behavioral Sciences 41 (2005): 249-267;
9. G. N. Grob, From Asylum to Community: Mental Health Policy in Modern America (Princeton, NJ: Princeton University Press, 1991);
10. G. N. Grob, The Mad Among Us: A History of the Care of America's Mentally Ill (Cambridge, MA: Harvard University Press, 1994);
11. E. Shorter, A History of Psychiatry: From the Era of the Asylum to the Age of Prozac (New York, NY: John Wiley & Sons, 1997).
12. R. Finbow, "Presidential Leadership or Structural Constraints? The Failure of President Carter's Health Insurance Proposals," Presidential Studies Quarterly 28 (1998): 169-186.
13. M. A. Lipton, A. DiMascio, and K. F. Killam, "Introduction and Historical Overview," in Psychopharmacology: A Generation of Progress, ed. M. A. Lipton, A. DiMascio, and K. F. Killam (New York, NY: Raven Press, 1978), xxiiii-xxvi.
14. Predictability in Psychopharmacology: Preclinical and Clinical Correlations, ed. A. Sudilovsky, S. Gershon, and B. Beer (New York, NY: Raven Press, 1975),
15. D. Healy, The Antidepressant Era (Cambridge, MA: Harvard University Press, 1997).
16. P. J. Hilts, Smoke Screen: The Truth Behind the Tobacco Industry Cover-Up (New York, NY: Addison-Wesley Publishing Company, 1996).
17. L. D. Hirshbein, "Scientific Research and Corporate Influence: Smoking, Mental Illness, and the Tobacco Industry," Journal of the History of Medicine and Allied Sciences 67 (2012): 374-397.
18. "Deposition of William Dunn, PhD," June 24, 1998, LTDL, Bates no. 3990137048/3990137517, http://legacy.library.ucsf.edu/tid/zsz82i00 (accessed August 1, 2014).
19. William Dunn to Wakeham, Seligman, Osdene, Fagan, Carpenter, Philip Morris, October 28, 1976, LTDL, Bates no. 1005127698, http://legacy.library.ucsf.edu/tid/mhh77e00 (accessed August 1, 2014).
20. CV of William Dunn, October 1978, LTDL, Bates no. 1003289004/9007, http://legacy.library.ucsf.edu/tid/icv97e00 (accessed August 1, 2014).
21. See letter from Maurice Lorr, professor at Catholic University, to Arthur Centor, American Psychological Association, June 14, 1976, LTDL, Bates no. 1003291406/1407, http://legacy.library.ucsf.edu/tid/kwv97e00 (accessed August 1, 2014).
22. Memo from Art Centor, American Psychological Association, to boards and committees in the association, June 29, 1976, LTDL, Bates no. 1003291408, http://legacy.library.ucsf.edu/tid/ewv97e00 (accessed August 1, 2014).
23. Andrew Scull, "Contested Jurisdictions: Psychiatry, Psychoanalysis, and Clinical Psychology in the United States, 1940-2010," Medical History 55 (2011): 401-406.
24. C. J. Acker, Creating the American Junkie: Addition Research in the Classic Era of Narcotic Control (Baltimore, MD: Johns Hopkins University Press, 2002).
25. J. H. Jaffe, "Cigarette Smoking as an Addiction," American Lung Association Bulletin 62 (1976): 10-12.
26. Draft of tobacco use disorder, proposed for DSM-III, March 1976, LTDL, Bates no. 2015063003/3027, http://legacy.library.ucsf.edu/tid/aup78e00 (accessed August 1, 2014).
27. Memo from Dunn to A. Holtzman, November 8, 1976, LTDL, Bates no. 2015063001/3002, http://legacy.library.ucsf.edu/tid/ztp78e00 (accessed August 1, 2014).
28. Memo from Horace Kornegay, Tobacco Institute, to Committee of Counsel, November 4, 1976, LTDL, Bates no. 03741588, http://legacy.library.ucsf.edu/tid/cdx61e00 (accessed August 1, 2014).
29. memo from E. A. Horrigan, September 1, 1981, LTDL, Bates 508511522, http://legacy.library.ucsf.edu/tid/cbi93d00 (accessed August 1, 2014).
30. Memo from Kornegay, Tobacco Institute, to Committee of Counsel, November 18, 1976, LTDL, Bates no. 03741589/1590, http://legacy.library.ucsf.edu/tid/unp99d00 (accessed August 1, 2014).
31. Memo from Kornegay to Committee of Counsel, November 24, 1976, LTDL, Bates no. 03741579/1580, http://legacy.library.ucsf.edu/tid/xcx61e00 (accessed August 1, 2014).
32. R. Bayer and R. L. Spitzer, "Neurosis, Psychodynamics, and DSM-III: A History of the Controversy," Archives of General Psychiatry 42 (1985): 187-196.
33. A. V. Horwitz, Creating Mental Illness (Chicago, IL: University of Chicago Press, 2002).
34. Richard C. Proctor to Robert Spitzer, December 7, 1976, LTDL, Bates no. 503683890, http://legacy.library.ucsf.edu/tid/zvn85d00 (accessed August 1, 2014).
35. Spitzer to Proctor, January 11, 1977, LTDL, Bates no. 503683878, http://legacy.library.ucsf.edu/tid/wvn85d00 (accessed August 1, 2014).
36. Proctor to Spitzer, [mid-January] 1977, LTDL, Bates no. 503683877, http://legacy.library.ucsf.edu/tid/vvn85d00 (accessed August 1, 2014).
37. Behavioral Analysis and Treatment of Substance Abuse, ed. N. A. Krasnegor (Rockville, MD: Department of Health, Education, and Welfare, 1979).
38. R. Bayer and R. L. Spitzer, "Edited Correspondence on the Status of Homosexuality in DSM-III," Journal of the History of Medicine and Allied Sciences 18 (1982): 32-52.
39. Draft of Tobacco Use Disorder, proposed for the DSM-III, March 25, 1977, LTDL, Bates no. 503683853/3857, http://legacy.library.ucsf.edu/tid/svn85d00 (accessed August 1, 2014).
40. M. Wilson, "DSM-III and the Transformation of American Psychiatry: A History," American Journal of Psychiatry 150 (1993): 399-410.
41. William W. Shinn to Arthur J. Stevens, Lorillard, November 10, 1978, LTDL, Bates no. 01335541/5542, http://legacy.library.ucsf.edu/tid/ozp99d00 (accessed August 1, 2014).
42. Memo from William D. Toohey, Jr. to "Spokesfolks," Tobacco Institute, December 9, 1980, LTDL, Bates no. T71671, http://legacy.library.ucsf.edu/tid/qbb76b00 (accessed August 1, 2014).
43. Letter from Proctor to Tarjan, October 22, 1982, LTDL, Bates no. 503945953, http://legacy.library.ucsf.edu/tid/wxa66b00 (accessed August 1, 2014).
44. Tarjan to Proctor, November 18, 1982, LTDL, Bates no. 503945948, http://legacy.library.ucsf.edu/tid/bbq75d00 (accessed August 1, 2014).
45. Drugs in America: A Documentary History, ed. D. F. Musto (New York, NY: New York University Press, 2002), 318-325
46. D. Healy, Pharmageddon (Berkeley, CA: University of California Press, 2012).
47. Tobacco Institute memo, April 27, 1984, LTDL, Bates no. TI08222367, http://legacy.library.ucsf.edu/tid/ecf92b00 (accessed August 1, 2014).
48. B. Shamasunder and L. Bero, "Financial Ties and Conflicts of Interest Between Pharmaceutical and Tobacco Companies," Journal of the American Medical Association 288 (2002): 738-744.
49. Advertisement printed in the Journal of the American Medical Association, March 2, 1984, LTDL, Bates 505016789, http://legacy.library.ucsf.edu/tid/szk35d00 (accessed August 1, 2014).
50. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (Washington, DC: American Psychiatric Association, 1987).
51. L. Rotskoff, Love on the Rocks: Men, Women, and Alcohol in Post-World War II America (Chapel Hill, NC: University of North Carolina Press, 2002).
52. M. Jarvik, "Conversation With Murray Jarvik," Addiction 96 (2001): 1241-1252.
53. K. Fagerström and N. G. Schneider, "Measuring Nicotine Dependence: A Review of the Fagerström Tolerance Questionnaire," Journal of Behavioral Medicine 12 (1989): 159-182;
54. K. Fagerström and H.-J. Aubin, "Management of Smoking Cessation in Patients With Psychiatric Disorders," Current Medical Research and Opinion 25 (2009): 511-518.
55. Practice Guideline for the Treatment of Patients With Nicotine Dependence (Washington, DC: American Psychiatric Association, 1996);
56. J. P. Docherty, P. M. Marzuk, and J. D. Barchas, "Editorial: Nicotine Dependence: Perspectives on a New Guideline From APA," American Journal of Psychiatry 153 (1996): 1247-1248.
57. John Huges Curriculum Vitae, http://www.uvm.edu/~psych/faculty/cv/Hughes-cv.pdf (accessed June 13, 2014).
58. American Psychiatric Association, "Position Statement on Nicotine Dependence," American Journal of Psychiatry 152 (1995): 481-482.
59. S. J. Heishman, L. T. Koslowski, and J. E. Henningfield, "Nicotine Addiction: Implications for Public Health Policy," Journal of Social Issues 53 (1997): 13-33.
60. John R. Hughes, "Treating Nicotine Dependence in Mental Health Settings," Journal of Practical Psychiatry and Behavioral Health 3 (1997): 250-254,
61. copy in LTDL, Bates no. 2081911947/1951, http://legacy.library.ucsf.edu/tid/goy81c00 (accessed August 1, 2014).
62. D. Ziedonis D, B. Hitsman, J. C. Beckham, et al., "Tobacco Use and Cessation in Psychiatric Disorders: National Institute of Mental Health Report," Nicotine and Tobacco Research 10 (2008): 1691-1715.
63. M. Zeller, D. K. Hatsukami, and Strategic Dialogue on Tobacco Harm Reduction Group, "The Strategic Dialogue on Tobacco Harm Reduction: A Vision and Blueprint for Action in the US," Tobacco Control 18 (2009): 324-332.
64. J. M. Williams, R. M. Anthenelli, C. D. Morris, et al., "A Randomized, Double-Blind, Placebo- Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder," Journal of Clinical Psychiatry 73 (2012): 654-660;
65. H.-J. Aubin, H. Rollema, T. H. Svensson, and G. Winterer, "Smoking, Quitting, and Psychiatric Disease: A Review," Neuroscience and Biobehavioral Reviews 36 (2012): 271-284.
66. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (Arlington, VA: American Psychiatric Association, 2013).
67. A. Frances, Saving Normal: An Insider's Revolt Against Out-of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life (New York, NY: Harper-Collins, 2013).
68. M. Angell, The Truth About the Drug Companies: How They Deceive Us and What to Do About It (New York, NY: Random House, 2004).
69. A. M. Brandt, "From Nicotine to Nicotrol: Addiction, Cigarettes, and American Culture," in Altering American Consciousness: The History of Alcohol and Drug Use in the United States, 1800-2000, ed. S. W. Tracy and C. J. Acker (Amherst, MA: University of Massachusetts Press, 2004), 383-402.
70. T. B. Baker, N. Breslau, L. Covey, and S. Shiffman, "DSM Criteria for Tobacco Use Disorder and Tobacco Withdrawal: A Critique and Proposed Revisions for DSM-5," Addiction 107 (2012): 263-275.
71. A. M. Brandt, "Inventing Conflicts of Interest: A History of Tobacco Industry Tactics," American Journal of Public Health 102 (2012): 63-71.
72. Nicotine Addiction: The Health Consequences of Smoking, a Report of the Surgeon General (Rockville, MD: Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health, 1988).
73. Philip Morris advertisement, May 1988, LTDL, Bates no. 2040596564, http://legacy.library.ucsf.edu/tid/rln56b00 (accessed August 1, 2014).
74. G. N. Grob, "The Attack of Psychiatric Legitimacy in the 1960s: Rhetoric and Reality," Journal of the History of the Behavioral Sciences 47 (2011): 398-416;
75. M. E. Staub, Madness Is Civilization: When the Diagnosis Was Social, 1948-1980 (Chicago, IL: University of Chicago Press, 2011).
76. Statement of Dr Stuart A. Kirk, July 1994, LTDL, Bates no. TIMN0329556/9574, http://legacy.library.ucsf.edu/tid/mhr52f00 (accessed August 1, 2014).
77. D. Kessler, A Question of Intent: A Great American Battle With a Deadly Industry (New York, NY: PublicAffairs, 2001).
78. "Expected testimony of Stuart A. Kirk," September 1987, LTDL, Bates no. 92464748/4749, http://legacy.library.ucsf.edu/tid/nmi54a00 (accessed August 1, 2014).
79. M. A. Steinman, L. A. Bero, M. M. Chren, and C. S. Landefeld, "Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents," Annals of Internal Medicine 145 (2006): 284-293;
80. D. J. Carlat, Unhinged: The Trouble with Psychiatry - A Doctor's Revelations About a Profession in Crisis (New York, NY: Free Press, 2010).
81. K. Helliker, "Nicotine Fix: Behind Antismoking Policy, Influence of Drug Industry," Wall Street Journal, February 7, 2007, http://whyquit.com/nrt/wsj-helliker-nicotine-fix-020807.html (accessed August 1, 2014).
82. Not surprisingly, the tobacco industry circulated this article; LTDL, Bates no. 3117185364-3117185369, http://legacy.library.ucsf.edu/tid/bou95g00 (accessed August 1, 2014).
83. K. Lasser, J. W. Boyd, S. Woolhandler, D. U. Himmelstein, D. McCormick, and D. H. Bor, "Smoking and Mental Illness: A Population-Based Prevalence Study," Journal of the American Medical Association 284 (2000): 2606-2610.
84. P. Belluck and B. Carey, "Psychiatry's Guide Is Out of Touch With Science, Experts Say," New York Times, May 6, 2013, http://www.nytimes.com/2013/05/07/health/psychiatrys-new-guide-falls-short-experts-say.html?-r=0 (accessed August 1, 2014).
85. A. Frances, "Is DSM 5 a Public Trust or an APA Cash Cow? Commercialism and Censorship Trump Concern for Quality," Psychology Today, January 3, 2012, http://www.psychologytoday.com/blog/dsm5-in-distress/201201/is-dsm-5-public-trust-or-apa-cash-cow (accessed August 1, 2014).